论文部分内容阅读
目的:分析在反流性食管炎中采用奥美拉唑联合法莫替丁治疗的疗效和安全性。方法:选取2013年6月到2014年12月到我院就诊的90例反流性食管炎患者,采用随机抽样的方法,将患者均分为对照组(采用奥美拉唑治疗)和观察组(采用奥美拉唑+法莫替丁治疗),每组各45例,比较两组患者的治疗效果和不良反应的发生情况。结果:观察组患者的治疗总有效率(95.56%)明显高于对照组(80.00%)(P<0.05);两组患者均未见严重不良反应。结论:采用奥美拉唑联合法莫替丁治疗反流性食管炎,疗效明显,安全性好,值得推广。
Objective: To analyze the efficacy and safety of omeprazole combined with famotidine in reflux esophagitis. Methods: Ninety patients with reflux esophagitis treated in our hospital from June 2013 to December 2014 were randomly divided into control group (treated with omeprazole) and observation group (Using omeprazole + famotidine treatment), 45 cases in each group, comparing the two groups of patients with treatment and adverse reactions. Results: The total effective rate (95.56%) in the observation group was significantly higher than that in the control group (80.00%) (P <0.05). No serious adverse reactions were observed in both groups. Conclusion: The combination of omeprazole and famotidine in the treatment of reflux esophagitis has obvious curative effect and good safety. It is worth to be popularized.